|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/737 |
| (11) | Patento numeris | 2953630 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14707953.7 |
| Europos patento paraiškos padavimo data | 2014-02-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-12-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/052406 |
| Data | 2014-02-07 |
| (87) | Numeris | WO 2014/122251 |
| Data | 2014-08-14 |
| (30) | Numeris | Data | Šalis |
| 201361762718 P | 2013-02-08 | US | |
| 201361811526 P | 2013-04-12 | US |
| (72) |
KLINGER, Matthias, DE
HOFFMANN, Patrick, DE
NAEGELE, Virginie, DE
DOPFER, Elaine-Pashupati, DE
NAGORSEN, Dirk, DE
SCHEELE, Juergen, DE
ZUGMAIER, Gerhard, DE
KUFER, Peter, DE
|
| (73) |
Amgen Research (Munich) GmbH,
Staffelseestrasse 2, 81477 München,
DE
|
| (54) | ANTI-LEUKOCYTE ADHESION FOR THE MITIGATION OF POTENTIAL ADVERSE EVENTS CAUSED BY CD3-SPECIFIC BINDING DOMAINS |
| ANTI-LEUKOCYTE ADHESION FOR THE MITIGATION OF POTENTIAL ADVERSE EVENTS CAUSED BY CD3-SPECIFIC BINDING DOMAINS |